All posts by imreal

New Study Shows That Aroma–Not THC–Drives the Cannabis Consumer Experience


True Terpenes Hemp Farm – Pacific Northwest

“The best way for a consumer to know whether they will enjoy smoking or vaping a particular flower is to smell it.”

In a new study published in the journal Psychoactives, some of the most influential minds in the industry today are breaking down the current understanding of what makes a “quality” cannabis experience. And to do so, they’ve done something even more groundbreaking: they’ve asked the consumer.

The study is the result of years of work led by a research team including esteemed breeder and cultivator Jeremy Plumb (Chair, Science Board & Head of Genetics & Cultivation at True Terpenes) and Ethan Russo, MD (neurologist and medical researcher, pioneer of the Entourage Effect, and Founding Member of the True Terpenes Science Board).

The results and methods of the research are outlined in the paper “The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower,” published November 8, 2022.

The study is revolutionary in its stated purpose: “to objectively identify features of cannabis that contribute to its appealing subjective effects.” In other words, to apply scientific methods to understanding what the consumer actually enjoys.

This alone is a huge step for the industry. And it has wide-reaching implications.

As the paper describes, one essential challenge to the sustainable growth of the industry (and the health of consumers) is the “potency effect of prohibition,” the phenomenon by which market value of cannabis is determined primarily by THC potency. This study lays the groundwork for a redefinition of value, based on the enjoyment of the consumer, as reported by the consumer.

The work is also novel in its approach. Until 2021, the National Institute on Drug Abuse (NIDA) was the single source for cannabis research on humans. (NIDA cannabis, as noted by the paper, “is not only genetically distinct from commercially available cannabis, but it also bears little chemical resemblance to the extensive variety of cannabis chemotypes sold in state-legal U.S. markets.”)

This study took a real-use approach, gathering consumer response data from 276 “judges” given 8-10 samples from a selection of 278 Oregon-grown organic craft cultivars that were entered into the Cultivation Classic cannabis competitions in 2019 and 2020.

The study found that, more than THC, “the strongest contribution to subjective appeal…was pleasant subjective aroma. That is, cannabis flowers with the most appealing aromas were the most likely to have the greatest subjective appeal.” The best way for a consumer to know whether they will enjoy smoking or vaping a particular flower is to smell it. THC potency was not identified by the study as an indicator of enjoyment. Rather, the results of the study point to the conclusion that “impairment and enjoyment are unrelated phenomena.”

“This paper should be a signal to the world that cannabis aroma is the most important dimension of character if your goal is to increase enjoyment of the product,” says Jeremy Plumb, who is currently building a library of chemovars based on aromatic expression with True Terpenes. “And the most meaningful evaluator of cannabis character is through sensory science.”

“In many ways consumers and patients have been effectively blinded from discovering their own relationship with the particular cannabis character they prefer at any given time. It’s a sensuous relationship, really. It relies on the senses being engaged. If we have built an industry that isn’t designed to optimize presentation and preservation of aroma at every step in the chain, from drying, packing, shipping, wholesaling and retailing, to the point where instead, the consumer mostly gets something that smells like hay, alfalfa, anaerobic, or inert, we have failed the task. We built it wrong. Start over.”

Visit https://trueterpenes.com/featured/the-nose-knows/ to read the full paper “The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower.”

Go to https://trueterpenes.com/sensory/ for tips and tools on integrating sensory analysis into your process.

Contact:

Alex Rumbolz

Marketing & Communications, True Terpenes

alex.rumbolz@trueterpenes.com

Share article on social media or email:

Cartessa Partners with AnteAGE MD® to Upgrade Solutions for its Skinwave System


New Skinwave Solutions

AnteAGE MD, a leader in medical grade skincare, carefully crafted three new solutions for the Skinwave system to provide maximum impact on the skin through exfoliation, decongestion, hydration and restoration.

Cartessa Aesthetics launched Skinwave, a multi-dimensional aqua-delivery system, in 2019 to aesthetic providers. The device featured three exclusive solutions, a unique hydrogen therapy step, and additional handpieces that elevated the overall aesthetic experience. Always working to improve upon their offerings, Cartessa is excited to announce new solutions formulated by AnteAGE MD®, exclusively for the Skinwave device.

AnteAGE MD, a leader in medical grade skincare, carefully crafted three new solutions to provide maximum impact on the skin through exfoliation, decongestion, hydration and restoration. Vice President of Products for AnteAGE MD® shared more about the carefully selected ingredients; “We worked hand in hand with Cartessa’s clinical and product team to select those actives that would be most complementary to their system. The solutions boast novel botanicals, enzymes, ceramides and lipids and to leave the skin with an ethereal glow.”

The new solutions further elevate the overall Skinwave experience which also includes unique steps like hydrogen therapy, electroporation with LED, and a lymphatic massage handpiece and provides a better financial model for providers.

When asked about the partnership between AnteAGE MD® and Cartessa, leaders of both organizations recognized the shared focus on efficacy and patient experience. “Innovative product development and education are values at Cartessa which mirror our own at AnteAGE®,” shared Ian Sanderson, President of AnteAGE®. Likewise, Gabe Lubin, Founder & CEO of Cartessa, recognizes the invaluable expertise the AnteAGE MD® team brought to maximizing the new Skinwave solutions. “Our business model allows us to partner with the best in the industry – from aesthetic technology manufacturers to skincare companies like AnteAGE ® that understand the science of skin and how to combine novel, quality ingredients that deliver results.”

The new solutions are now available to all Skinwave owners to order on the Cartessa store. To learn more about Skinwave and details about the new solutions, visit http://www.cartessaaesthetics.com/skinwave or reach out to your local Cartessa Aesthetics representative.

About Cartessa Aesthetics

Cartessa Aesthetics is a leading North American aesthetic company focused on cutting-edge technology and industry leading customer support. Thanks to an independent business model and established relationships with top global manufacturers, Cartessa’s product portfolio offers true competitive advantages for practices and patients across every aesthetics category. Customers benefit from expertly vetted devices and end-to-end support to maximize the clinical outcomes and returns of their investment.

About AnteAGE MD®

Based in Irvine, California, the AnteAGE MD® team is regularly published in scientific journals, awarded for groundbreaking results, and sought after for their expertise by Fortune 100 healthcare companies. AnteAGE MD®’s mission is to provide powerful regenerative anti-aging products through sound evidence-based technologies.

Share article on social media or email:

HealthyChildren.org Celebrates the Holidays With a 7-Day Sweepstakes Event


Join us in our Holiday Sweepstakes event!

HealthyChildren.org, the official American Academy of Pediatrics (AAP) website for parents, celebrates the holidays by giving away seven $200 gift cards in the site’s Holiday 2022 Sweepstakes event.

Registered users of HealthyChildren.org may enter once each day during the event which runs December 5 through December 11, 2022. Winners will be drawn daily and announced on Facebook as they are confirmed. View the full contest rules.

About HealthyChildren.org

The only parenting website backed by 67,000 AAP member pediatricians, HealthyChildren.org offers trustworthy, up-to-the-minute health advice and guidance for parents and caregivers, along with interactive tools and personalized content. Registered users enjoy a customized home page as well as a free monthly e-newsletter. A new Ages & Stages program offers parents of young children (as well as those who are expecting a new baby) weekly texts and/or monthly emails based on the age(s) of their child(ren). The site also offers a Find a Pediatrician service, an Ask the Pediatrician tool, a KidsDoc Symptom Checker, and more than 5,000 articles in English and Spanish.

Share article on social media or email:

Top Plastic Surgeon Dr. Erez Dayan Selected as Course Director at the Upcoming South American Plastic Surgery Society meeting in Cartagena, Colombia


News Image

“Receiving the invitation to be the course director for this conference in Cartagena is truly an honor, especially in South America where some of my most admired colleagues are from,” says Dr. Erez Dayan.

Dr. Erez Dayan will be contributing his deep knowledge as course director to educate plastic surgeons on advanced liposuction and emerging body contouring technologies.

This impressive event will provide a unique platform for those in the field of plastic surgery and aesthetics to stay up-to-date on the latest methodologies and technologies in this ever-changing medical field. Dr. Dayan is a highly sought-after international educator, lecturer and researcher, publishing journal articles and books on various plastic surgery topics. Dr. Dayan is co-author of Emerging Technology in Face & Body Contouring. Internationally regarded as the authoritative textbook in this sector. Dr. Dayan has been at the forefront of plastic surgery research, emerging innovations, and minimally invasive modalities for aesthetic treatments over the past 10 years. He serves as co-investigator for industry-sponsored grants and is a lead investigator for FDA trials of emerging aesthetic prototype devices.

Dr. Erez Dayan completed his training at the elite Harvard Plastic Surgery program before going on to achieve a fellowship in aesthetic surgery at the world-class Dallas Plastic Surgery Institute. Dr. Dayan provides comprehensive aesthetic treatments for the face, breast, and body, as well as reconstructive surgery. From cosmetic procedures such as facelifts, breast augmentations, rhinoplasty and abdominoplasty, to more customized, unique treatments such as radiofrequency or ultrasound skin tightening, and fat transfer techniques, Dr. Dayan applies an industrious, precision-based approach that reflects his innate penchant for excellence.

“Receiving the invitation to be the course director for this conference in Cartagena is truly an honor, especially in South America where some of my most admired colleagues are from,” says Dr. Erez Dayan.

More about Dr. Erez Dayan:

Avance Plastic Surgery Institute, located at 5588 Longley Lane, in Reno, Nevada, is one of the foremost plastic surgery institutes of its kind. Dr. Dayan’s practice offers cutting-edge technology, advanced surgical procedures and a full range of aesthetic facial and body treatments. Patients can expect a customized treatment plan that is developed from a menu of aesthetic options, including surgical, minimally invasive and non-invasive. When undergoing a cosmetic procedure performed by a skilled plastic and reconstructive surgeon such as Dr. Dayan, patients can expect to look and feel more youthful and vibrant, with a sense of improved confidence and personal satisfaction with their image. To schedule a consultation or for more information on his upcoming events, please call 775-800-4444 or visit http://www.avanceplasticsurgery.com or Instagram @avanceplasticsurgery__

Share article on social media or email:

Capsa Healthcare’s NexsysADC For Ambulance & Emergency Medical Response Medications


News Image

There are so many inherent concerns in the emergency response industry already. NexsysADC brings the risk down for medications.

Capsa Healthcare, a leading innovator in healthcare delivery solutions, announced its NexsysADC automated medication dispensing system now accommodates ambulance and EMS medical services. NexsysADC’s electronic management of on-hand drug inventory and user tracking will ensure first responders have the right dose onboard, without delay or discrepancy. This new application is part of Capsa Healthcare’s continual expansion of NexsysADC’s versatility.

With the new EMS workflow, NexsysADC controls all aspects of medication storage, restocking, and dispensing. It ends the chance for medication stock mishaps during emergency response.

1. Medication doses are stored inside a NexsysADC cabinet at the home base (typically the fire house contracts with a local hospital or institutional pharmacy for medication inventory)

2. Allows access only for authorized personnel

3. Organizes the restocking for each specific ambulance

4. Tracks every dose by ambulance, driver, time

5. Manages inventory levels inside the fire house and aboard each ambulance

6. Heightened security for controlled doses (e.g., fentanyl and ketamine)

7. Real-time reports for all activities

NexsysADC is a dramatic improvement over the manual “go-bag” or “squad box” approach to equip ambulances with medication doses. In too many jurisdictions, medications are locked in a safe or closet at the fire station; the ambulance driver turns in a paper ride sheet, and the go-bag is restocked and noted in a log book. Without computerized safeguards in place, ambulances risk expired or missing doses which could compromise emergency treatment, and record-keeping is poor.

“Missing doses and incorrect inventory are common concerns anywhere controlled or expensive meds are stored and dispensed. The ambulance setting adds even more challenges like dangerously critical patients, tight turnarounds, elevated stress, mobility” says Chris Miller, product director for Capsa Healthcare. “NexsysADC takes care of everything concerning the medications onboard so the EMT professionals can confidently respond to anything.”

NexsysADC is the reasonably sized and priced automated dispensing cabinet (ADC) system for healthcare settings that require secure, trackable storage of medication doses – especially controlled medications. NexsysADC is the trusted technology in settings like long-term care, veterinary, surgery centers, and behavioral health. Now, the unique benefits of NexsysADC can adapt to the specialized workflow needs of ambulance and EMT professionals.

“Instant improvement” is how Miller describes the reaction from emergency response teams that piloted the new NexsysADC workflow software in the United States and The Netherlands. “There are so many inherent concerns in this industry like cost containment, DEA audits, wasted time, and the potential for a needed med to not be readily accessible. NexsysADC brings the risk down.”

About Capsa Healthcare

Capsa Healthcare is a worldwide leader in developing and delivering innovative healthcare solutions for a wide spectrum of care providers. With 60+ years of experience, Capsa Healthcare offers a unique ability to meet the demands of diverse healthcare environments and offers a broad range of products including medication carts, medical carts, point-of-care carts, and pharmacy automation solutions. Headquartered in Columbus, OH, Capsa Healthcare has over 400 employees with management, sales, and production offices throughout the world. For more, visit http://www.capsahealthcare.com or call 800-437-6633.

Follow Capsa Healthcare on Facebook (https://www.facebook.com/capsahealthcare/), Twitter (https://twitter.com/CapsaHealthcare), and LinkedIn (https://www.linkedin.com/company/capsahealthcare).

Share article on social media or email:



Breast Ultrasound Wellness Clinic Launches in San Francisco


News Image

“At Eve Wellness, we are excited to provide state-of-the-art, radiation-free ultrasound screening for women who are proactive about their breast health.”

The first clinic of its kind in the region, Eve Wellness will provide women access to FDA-approved breast ultrasounds for preventative care and the earlier detection of breast cancer. At Eve Wellness, we use the GE ABUS ultrasound and QView AI (1 of only 20 of ABUS/AI combinations that exist in the country). This combination is the most advanced technology of its kind and a very unique offering to women in San Francisco. It’s radiation-free, safe, convenient, and you receive your results within 48 hours. No doctor’s referral needed.

“At Eve Wellness, we are excited to provide state-of-the-art, radiation-free ultrasound screening for women who are proactive about their breast health. We believe modern imaging technology enables women to detect abnormalities before they feel them and that provides many more options and better outcomes.”- Richard Blunck, Co-Founder

In 2013, California passed a law requiring physicians practitioners to inform women if they have “dense tissue”. Almost fifty percent of women in the United States have dense breast tissue. Eighty percent of women under fifty have this tissue type. Screening with ultrasound sees through this density and finds those abnormalities which are not visible in mammography.

Eve’s mission is to provide women with dense breast tissue early and convenient access to ultrasound screening as part of their preventive healthcare practice. As we know, early detection is key in breast cancer.

“For over three decades, I have watched my father and his colleagues create innovative and clinically successful technologies for earlier detection of breast cancer. The Eve Wellness team is committed to advancing the cause by enabling women to screen with ultrasound earlier and more frequently. Finding cancers earlier can lead to less intensive treatment and therapies Three million women in the USA are living today having been treated for breast cancer. With earlier detection and new therapies we may reduce the mortality rate.” – Brendan Foley, Co-Founder

Eve Wellness is now open at 2102 Union Street, San Francisco, CA and currently booking appointments online at http://www.myevewellness.com.

About Eve

A New Way to Screen For Breast Cancer. Our advanced, FDA-Approved ultrasound technology coupled with FDA-Approved Artificial Intelligence lets you screen earlier and more frequently to stay on top of your breast health. It’s more comfortable than a mammogram, less expensive than MRI, quick and convenient, and there is no risk of radiation exposure.

Whether you have a family history of breast cancer, have dense breast tissue, or simply want to be proactive about your breast health, Eve Wellness provides you with the screening and education you need to stay healthy, all in a comfortable spa-like environment.

For more information, please visit http://www.myevewellness.com.

For additional information:

Brendan Foley

Chief Marketing Officer, Eve Wellness

E: press@myevewellness.com

Share article on social media or email:

White House Summit on COVID-19 Equity and What Works Showcase


After administering over 2 million COVID-19 vaccines in 10 states with a focus on communities lacking historical health care access, we believe that strong private-public partnerships and key data insights are the future of public health.

For many community-based organizations, the COVID-19 response has placed equity squarely at its center. Public health collaborations in communities across the country have focused on protecting, supporting and uplifting hard-hit, high-risk communities in the face of the unprecedented public health threat. While there remains much to do in pursuit of health equity, the White House Summit on COVID-19 Equity and What Works Showcase highlights interventions and approaches that have moved the needle on equitable COVID-19 outcomes and showcases a path forward.

This event, held virtually on November 16, 2022, convenes community organizations, equity leaders, government officials and philanthropic organizations in the sharing of best practices to light the way forward.

Taking part in the showcase include the Wellness & Equity Alliance (WEA), a national organization of public health clinicians working to close gaps in population and public health, and RS21, a data science company with a Health Lab dedicated exclusively to healthcare analytics. The two organizations will share strategies and best practices learned through a partnership together that has focused on bolstering WEA’s responsive, equitable approaches to providing direct access to COVID-19 services in communities at the U.S.-Mexico border by using RS21’s data, analytics, and machine learning capabilities. Speakers include Dr. Tyler B. Evans, WEA CEO and Co-Founder, Dr. Christina Madison, WEA Chief Pharmacist and Public Information Officer, and Angelica Maestas, RS21 Health Lab Division President.

“COVID-19 amplified the inequities in the health system that have existed for decades and predated on vulnerable public health systems that intended to protect the most marginalized communities in the U.S. After administering over 2 million COVID-19 vaccines in 10 states with a focus on communities lacking historical health care access, we believe that strong private-public partnerships and key data insights are the future of public health,” said Dr. Evans.

“The goal in using big data and machine learning is to make new information visible that moves us beyond traditional delivery of health care and focuses on early public health interventions that make a difference in our communities and the people who live within them,” added Maestas.

The discussion will center on building relationships with public health departments and local news outlets and using data to develop targeted approaches to reach the highest-risk communities with COVID-19 services, such as vaccinations and treatments. Through these relationships and data-driven strategies, WEA deployed “pop-up” mobile clinics to vaccinate and educate over 1,000 patients that live in colonias, or unincorporated villages along the southern U.S. border with nearly 2 million inhabitants living in abject poverty, in Laredo, TX.

This and other sessions are featured as a virtual showcase to demonstrate groundbreaking work on COVID-19 equity. Panel discussions are live streamed. More information can be found online at https://rs21.io/white-house-covid19-equity-summit.

The White House is joined by the Centers for Disease Control and Prevention in hosting this event.

About Wellness & Equity Alliance

Wellness & Equity Alliance (WEA) is a novel national public health organization comprised of a multidisciplinary team of clinicians, community health workers and population health experts with expertise in infectious disease, public health, emergency medicine, primary care, cardiology, pediatrics, psychiatry, community health work (CHW), nursing and advanced practice pharmacy. They work nearly exclusively with underrepresented communities, fundamentally addressing health-care disparities and the social determinants of health (SDoH) that have been amplified during the COVID-19 pandemic, prioritizing the following: people experiencing homelessness, indigenous communities, immigrant communities, rural communities, BIPoC communities, LGBTQ+ communities and justice-impacted communities.

About RS21

RS21 is a rapidly growing data science company that uses artificial intelligence, design, data engineering, and modern software development methods to empower organizations to make data-driven decisions that positively impact the world. Our innovative solutions are insightful, intuitive, inspiring, and intellectually honest. With offices in Albuquerque, NM and Washington, DC, RS21 is an Inc. 5000 fastest-growing company and a Fast Company Best Workplace for Innovators.

We help clients achieve programmatic goals, improve efficiencies, reduce costs, and maximize productivity using MOTHR, our human-centered, artificial intelligence engine that allows users to seamlessly integrate data and reveal insights at hyper speed. We navigate complex data issues in the fields of healthcare, defense, safety, urban planning, energy, cyber, land use, climate, disaster preparedness, disaster recovery, space, and social equity. Visit http://www.rs21.io.

Share article on social media or email:

Fifteen Health Departments Awarded Accreditation or Reaccreditation Status by the Public Health Accreditation Board


News Image

“Public health departments are the backbone of our public health system,” said PHAB President and CEO Paul Kuehnert, DNP, RN, FAAN. “Ensuring that they have a strong infrastructure and Foundational Capabilities in place is a vital step in strengthening the health of communities across the country.”

The Public Health Accreditation Board (PHAB) today announced the names of fifteen public health departments that have achieved accreditation or reaccreditation status, after completion of a systematic review process against national standards. These health departments have demonstrated their commitment to building and maintaining a strong infrastructure to better serve their communities.

“Accreditation establishes Ohio’s state and local health departments among the nation’s leaders in public health planning and action,” said Bruce Vanderhoff, MD, MBA, Director of the Ohio Department of Health. “It is an important demonstration of our commitment to delivering the highest quality of public health service to the people of Ohio.”

Health departments provide essential services, such as such as vaccinations, food inspections, health education, and vital records, and are key leaders in improving the health and well-being of communities. To demonstrate accountability, promote transparency, and adopt cultures that promote continuous performance improvement, many health departments strive to achieve national accreditation.

“Achieving accreditation is a reflection of our commitment to our Washington County community and is the result of years of dedication and extraordinary effort on behalf of our staff, our partners and our volunteers,” said John Jackson, Director of Washington County Health Department, OH. “While becoming an accredited health department was our goal, it is the process of gaining accreditation that will lead to improved health outcomes within our county.”

PHAB, the non-profit organization that administers the national accrediting program, works to improve and protect the health of the public by advancing and transforming the quality and performance of governmental public health departments in the United States and abroad.

“Public health departments are the backbone of our public health system,” said PHAB President and CEO Paul Kuehnert, DNP, RN, FAAN. “Ensuring that they have a strong infrastructure and Foundational Capabilities in place is a vital step in strengthening the health of communities across the country.”

National Initial Accreditation was awarded November 4, 2022 to:

  • Ashtabula County Health Department, OH
  • City of Middletown Health Department, OH
  • Morrow County Health District, OH
  • Noble County Health Department, OH
  • Washington County Health Department, OH

National Reaccreditation was awarded November 4, 2022 to:

  • City of Long Beach Department of Health and Human Services, CA
  • Flathead City-County Health Department, MT
  • Garrett County Health Department, MD
  • Gwinnett, Newton and Rockdale County Health Departments, GA
  • Ohio Department of Health, OH
  • Sedgwick County Health Department, KS
  • St. Croix County DHHS-Public Health, WI
  • Stratford Health Department, CT
  • Taney County Health Department, MO
  • Washington County Department of Public Health and Environment, MN

Share article on social media or email:

AHN Hospitals Receive “A” Grades in National Patient Safety Report


“Our team members earn these ‘A’ grades every day in our hospitals, and across every AHN touchpoint, and it’s gratifying to have those exceptional efforts consistently recognized by respected, independent organizations like Leapfrog,” said Brian Parker, MD, AHN’s Chief Quality Officer.

AGH, Forbes, Grove City, Saint Vincent and West Penn Hospitals Lauded by Leapfrog Group for Care Excellence

Five Allegheny Health Network (AHN) hospitals have earned the highest possible safety rating of “A” grades in The Leapfrog Group’s fall 2022 survey, a national report that recognizes hospitals for the quality and safety of the care they provide to patients.

The Leapfrog Group is a national nonprofit organization committed to improving health care quality and safety for patients and purchasers. Updated and published each spring and fall, the “Safety Grade” report assigns an A, B, C, D, or F grade to hospitals across the country, based on their performance in preventing medical errors, injuries, accidents, infections, and other harm to patients under their care.

In the report, issued this week, AHN’s Allegheny General (AGH), Forbes, West Penn, Grove City and Saint Vincent Hospitals all received “A” grades.

“At AHN, our team members are dedicated to providing safe, high-quality services and care for patients with great empathy and compassion,” said Brian Parker, MD, AHN’s Chief Quality Officer. “They earn these ‘A’ grades every day in our hospitals, and across every AHN touchpoint, and it’s gratifying to have those exceptional efforts consistently recognized by respected, independent organizations like Leapfrog.”

The Leapfrog Hospital Safety Grade uses up to 27 measures of publicly available hospital safety data to assign grades to more than 3,000 U.S. acute-care hospitals, twice per year. The Hospital Safety Grade’s methodology is peer-reviewed, and the results are totally transparent and free to the public.

As AHN’s flagship academic medical center, AGH is a leading provider of advanced critical care and home to some of the nation’s premier institutes for cancer care, cardiovascular medicine and surgery, neurosurgery, orthopaedic surgery, trauma and organ transplantation, among other specialties. AGH has earned an “A” grade for three consecutive scoring periods in the Leapfrog Group’s bi-annual patient safety survey.

AHN Forbes has provided comprehensive, personalized care to residents of Pittsburgh’s eastern suburbs for more than 40 years, including the region’s only Level 2 Trauma Center, it’s only obstetrics program that delivers 1,300 babies every year; and state-of-the-art cancer, cardiovascular, orthopedics and neurosurgical care, among many other specialties.

AHN West Penn, AHN’s flagship hospital for women’s and infants care, is home to a Level III Neonatal Intensive Care Unit and AHN Women’s Behavioral Health. It’s also a leading provider of stem cell transplantation therapy, gynecologic oncology treatment, care for autoimmune diseases and burn care, among other specialties.

AHN Grove City is a 67-bed community hospital that has provided care in Mercer County for nearly 45 years. The hospital is a Level IV Trauma Center and serves as a conduit to many AHN specialized services, offering the community close-to-home access to the medical and surgical care patients need.

AHN Saint Vincent is a full-service tertiary hospital that provides the greater Erie County region with access to comprehensive health care services, including obstetrics and gynecologic surgery, cancer care, cardiovascular care, neurosurgery and orthopaedic surgery, among other specialties. This represents Saint Vincent’s 5th consecutive “A” grade rating from Leapfrog.

“We could not be prouder of our physicians, nurses and team members at every level for the exceptional work they do to help us meet the highest standards of safety in the care we provide for our patients,” said Amy Cotton, DNP, Senior Vice President Quality and Safety. “We deeply appreciate the Leapfrog Group for validating what we already know—our talented healthcare providers make the safety and well-being of our patients their top priority and they deserve to be celebrated.”

To view the complete list of Pennsylvania hospital Leapfrog grades, visit

https://www.hospitalsafetygrade.org.

Share article on social media or email: